Skip to main content

Animations

MJFF Publications

511 - 520 of 6570 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2023
  • 2023
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.705407
    Citation Count: 86
  • Summary Details
    OPEN
    Title: A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00239-x
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-021-00513-5
    Citation Count: 107
  • Summary Details
    OPEN
    Title: Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-39060-w
    Citation Count: 138
  • Summary Details
    OPEN
    Title: Subsensory stochastic electrical stimulation targeting muscle afferents alters gait control during locomotor adaptations to haptic perturbations
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2023.107038
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Perception and Use of Compensation Strategies for Gait Impairment by Persons With Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012633
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Sex differences for phenotype in pathologically defined dementia with Lewy bodies
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2020-325668
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Copy Number Variation in Parkinson's Disease: An Update from Sub‐Saharan Africa
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28710
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.28715
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Brain proteome-wide association study implicates novel proteins in depression pathogenesis
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-021-00832-6
    Citation Count: 173
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.